Ceribell with Clarity offers 24/7 bedside EEG monitoring and alerts

At the bedside, Clarity provides:

First FDA-cleared instantaneous bedside alert indicating suspected status epilepticus

Continuous EEG monitoring and seizure burden display*

Remotely, Clarity provides:

First FDA-cleared seizure burden trend for effective seizure management

Accurate EEG seizure burden labeling

Real-time medication effectiveness

Easily annotate medications at the bedside with just a touch

Intuitive medication response monitoring for treatment optimization in real-time

Clinical Impact

Clarity provides consistently high performance that minimizes inter-rater variability⁵³

100%

sensitivity in detecting and alerting for status epilepticus

88%

sensitivity for identifying epileptiform activity

99%

accuracy in ruling out seizure and seizure-like activity

Economic Impact

Clarity Enhances your EEG capability to 24/7 on-site monitoring while helping you realizing significant savings

Have 24/7 bedside EEG monitoring at a fraction of the cost
Minimize delays in treating non-convulsive status epilepticus
Avoid unnecessary anti-seizure medications and treatment
Avoid unnecessary patient transfers
Reduce patient’s length of stay

*Seizure burden is defined by the American Clinical Neurophysiology Society (ACNS) as the percentage of time that EEG shows seizure activity.
American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology: 2012 version. Journal of Clinical Neurophysiology, Volume 30, Number 1, February 2013